AI brief of an SEC Form 8-K · Amn Healthcare Services (AMN)
AMN Healthcare Q3 revenue up 13% to $717 million; Q4 outlook sees 10-12% drop
AMN Healthcare reported third-quarter 2026 revenue of $717.3 million, up 13% from a year earlier, with GAAP diluted EPS of $0.83 versus $0.76 and adjusted diluted EPS of $1.16 versus $0.39. The company guided fourth-quarter revenue to $655 million to $670 million, 10-12% below the prior year, with operating margin of (0.1%) to 0.5%, so shareholders face a sharp expected slowdown after a quarter boosted by labor disruption revenue.
Key points
- Q3 2026 revenue $717.3 million, up 13% year over year; GAAP net income $33.4 million
- GAAP diluted EPS $0.83 vs $0.76 a year ago; adjusted diluted EPS $1.16 vs $0.39
- Q3 labor disruption revenue $59 million vs $12 million in Q3 2025
- Q4 2026 guidance: revenue $655-670 million, operating margin (0.1%) to 0.5%, labor disruption revenue assumed at $5 million vs $124 million in Q4 2025
The filing
CompanyAmn Healthcare Services (AMN)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:16 PM ET
Accession number0001142750-26-000011
Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.